Literature DB >> 28630142

The WHO joint statement from funders on trials transparency.

Ben Goldacre1.   

Abstract

Mesh：

Year:  2017        PMID： 28630142     DOI： 10.1136/bmj.j2816

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

Review 1.  Integrity of clinical research conduct, reporting, publishing, and post-publication promotion in rheumatology.

Authors:  Durga Prasanna Misra; Vikas Agarwal
Journal:  Clin Rheumatol       Date:  2020-02-05       Impact factor: 2.980

2.  Coronavirus Disease 2019 Related Clinical Studies: A Cross-Sectional Analysis.

Authors:  Lin-Lu Ma; Xuan Yin; Bing-Hui Li; Jia-Yu Yang; Ying-Hui Jin; Di Huang; Tong Deng; Yun-Yun Wang; Xue-Qun Ren; Jianguang Ji; Xian-Tao Zeng
Journal:  Front Pharmacol       Date:  2020-09-02       Impact factor: 5.810

3.  Data sharing from pharmaceutical industry sponsored clinical studies: audit of data availability.

Authors:  Ashley M Hopkins; Andrew Rowland; Michael J Sorich
Journal:  BMC Med       Date:  2018-09-28       Impact factor: 8.775

4.  The Challenge of Transparency and Validation in Health Economic Decision Modelling: A View from Mount Hood.

Authors:  Seamus Kent; Frauke Becker; Talitha Feenstra; An Tran-Duy; Iryna Schlackow; Michelle Tew; Ping Zhang; Wen Ye; Shi Lizheng; William Herman; Phil McEwan; Wendelin Schramm; Alastair Gray; Jose Leal; Mark Lamotte; Michael Willis; Andrew J Palmer; Philip Clarke
Journal:  Pharmacoeconomics       Date:  2019-11       Impact factor: 4.981

5.  Top health research funders' guidance on selecting journals for funded research.

Authors:  Larissa Shamseer; Kelly D Cobey; Matthew J Page; Jamie C Brehaut; Jeremy M Grimshaw; Sharon E Straus; Lesley A Stewart; David Moher
Journal:  F1000Res       Date:  2021-02-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.